Kroeze, Stephanie G. C. https://orcid.org/0000-0002-1342-5310
Schaule, Jana
Fritz, Corinna
Kaul, David
Blanck, Oliver
Kahl, Klaus H.
Roeder, Falk
Siva, Shankar
Verhoeff, Joost J. C.
Adebahr, Sonja
Schymalla, Markus M.
Glatzer, Markus
Szuecs, Marcella
Geier, Michael
Skazikis, Georgios
Sackerer, Irina
Lohaus, Fabian
Eckert, Franziska
Guckenberger, Matthias
Funding for this research was provided by:
Varian Medical Systems
Article History
Received: 28 October 2020
Accepted: 6 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: This study was approved by the ethics committees at all participating sites (BASEC-Nr. 2016-01807). A informed consent of all participants was obtained.
: Not applicable.
: SA is supported by the German Cancer Consortium (DKTK), M Geier received a speaker fee from Roche and a speaker fee from Bristol-Myers-Squibb. SS is supported by a National Health and Medical Research Council (NHMRC) fellowship, and Cancer Council Victoria (CCV) Colebatch Fellowship. MS received a speaker fee from Merck Serono, AstraZeneca and Pierre Fabre. SK received a speaker fee from AstraZeneca.